Скачать или смотреть IBRX Stock Analysis | Immunitybio EXPLODING as i PREDICTED! | What's Next Target?

One month ago, I called IBRX at $2.14 when everyone else was sleeping on it. Today it hit $6.93 - a 220% explosion in just 30 days. In this video, I break down exactly how we predicted this move, what's driving the surge, and most importantly, what you need to watch next.

📊 WHAT I COVER IN THIS VIDEO:
✅ The exact technical setup that predicted the 220% move
✅ Three fundamental catalysts driving the explosion
✅ Wall Street analyst targets: $9-$12 range breakdown
✅ Risk analysis: Legal investigation & dilution threats
✅ Two tactical playbooks: Short-term traders vs. Long-term investors
✅ Three critical signals determining the next move
✅ My price targets and entry zones going forward

💰 KEY NUMBERS YOU NEED TO KNOW:
• Entry Point: $2.14
• Current Price: $6.93
• Gain: 220% in 30 days
• Sales Growth: 700% year-over-year
• ANKTIVA Revenue: $113 Million
• Analyst Consensus Target: $11.80
• Volume Baseline to Watch: 44 Million

⚠️ CRITICAL FACTORS TO MONITOR:
🔸 Legal Investigation: Active securities fraud inquiry creating uncertainty
🔸 Cash Runway: Limited capital may force dilution through share offerings
🔸 RSI Levels: Watch for overbought conditions above 70
🔸 50-Day Moving Average: Key support level for momentum continuation
🔸 ResQ215B Phase 2 Trial: Major binary catalyst event ahead

👇 SUBSCRIBE TO STOCKS WITH DAVID NOW 👇

📈 ABOUT STOCKS WITH DAVID
Welcome to Stocks with David! My channel is dedicated to helping you navigate the US Stock Market and the NASDAQ.
Whether you are looking for daily market updates, deep dives into tech stocks or long-term investing strategies, this channel provides the data and analysis you need. I break down complex financial charts and news into simple, actionable insights to help you build wealth and manage your portfolio.
⚠️ DISCLAIMER: NOT FINANCIAL ADVICE
The content provided on the Stocks with David YouTube channel and in this video is for entertainment and educational purposes only. I am not a professional financial advisor.
#stockmarket #IBRXStock #ShortSqueeze #Stocks With David